Elite Pharmaceuticals Inc (ELTP)

[BostonTrader]

The problem is that isn't how drug stocks work though in the currently painted scenario. Drug stocks move on approval not when the revenues actually come in, they trade on future prospects. The issue here is that if approval is a layup and revenues are sure to come, then people would be buying right now in droves. That is unless something else is making the buyers pause which is the case at the moment. Don't know what it is, but it's happening at the moment.